Table 3 Baseline characteristics in CAD patients with or without MACE
Characteristics | MACE | p | |
|---|---|---|---|
Present, n = 102 | Absent, n = 415 | ||
Age (yrs) | 64.8 ± 12.1 | 63.1 ± 11.2 | 0.168 |
Male (%) | 86.3 | 81.4 | 0.251 |
Smokers (%) | 30.4 | 39.3 | 0.155 |
Hypertension (%) | 66.7.00 | 56.70 | 0.105 |
Diabetes mellitus (%) | 30.4 | 21.9 | 0.071 |
History of AMI (%) | 35.5 | 36.8 | 0.782 |
History of stroke | 4.9 | 4.6 | 0.798 |
Previous PCI | 22.5 | 15.7 | 0.097 |
SBP (mmHg) | 134.9 ± 23.2 | 129.7 ± 20.4 | 0.022 |
Body mass index (kg/m2) | 20.8 ± 7.6 | 21.4 ± 8.2 | 0.751 |
Total cholesterol (mmol/L) | 4.39 ± 1.27 | 4.44 ± 1.22 | 0.681 |
Triglycerides (mmol/L) | 1.17 (0.87, 1.69) | 1.30 (0.98, 1.81) | 0.306 |
LDL-C (mmol/L) | 2.71 ± 1.04 | 2.75 ± 0.99 | 0.729 |
HDL-C (mmol/L) | 1.08 ± 0.29 | 1.10 ± 0.30 | 0.627 |
Lp(a) (mg/dl) | 36.3 (12.8, 56.4) | 22.4 (10.5, 45.7) | 0.012 |
hs-CRP (mg/l) | 3.34 (1.48, 6.80) | 3.33 (1.35, 10.80) | 0.200 |
eGFR (ml/min/1.73 m2) | 92.9 ± 34.1 | 97.5 ± 33.7 | 0.228 |
HbAc1 (%) | 6.52 ± 0.98 | 6.41 ± 1.21 | 0.496 |
LVEF (%) | 56.0 ± 13.7 | 59.8 ± 10.9 | 0.003 |
Coronary type | |||
Stable angina | 33.3 | 22.9 | 0.029 |
Unstable angina | 28.4 | 39.5 | 0.038 |
AMI | 38.2 | 37.6 | 0.904 |
Number of lesion vessels | 2.34 ± 0.76 | 2.15 ± 0.81 | 0.034 |
Three-vessel disease | 52.0 | 41.9 | 0.067 |
Left main disease | 16.7 | 11.8 | 0.188 |
Statins | 100 | 98.1 | 0.366 |
β-blockers | 74.5 | 81.4 | 0.103 |
ACE inhibitors/ARB | 81.4 | 80.7 | 0.881 |